Table 4 Input parameters for lamotrigine GastroPlus PBPK model.

From: A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) modelling and simulation

 

Parameters

Values/models

Physiochemical and blood binding properties

Molecular weight (g/mol)

256.1a

LogP

1.19b

pKa

5.5b

Solubility (mg/mL) (pH = 7)

0.17a

B:P

1b

fup

0.45c

Absorption

Absorption model

ACATd

Peff (10−4 cm/sec)

7.761c

Diffusion coefficient (10−5 cm2/sec)

0.92d

Dissolution model

Johnsond

Particle size distribution

Log-normald

Particle radius (µm)

25d

Particle density (g/mL)

1.2d

Dose volume (mL)

250d

Precipitation model

First orderd

Precipitation time (sec)

900d

Paracellular model

Zhimind

Distribution

Distribution model

Full PBPK-Poulin & Theil (homogeneous)d

Vss (L/kg)

1.16c,e

Elimination

CLIV (L/h)

2c

fCL,renal (CLR in L/h)

0.10 (0.2)a

fCL,hepatic (CLH in L/h)

0.90 (1.8)a

Metabolic clearance

CLuint,H in L/h

4.09a

fm,UGT (CLuint,UGT in L/h)

0.86 (3.91)a

fm,CYP (CLuint,CYP in L/h)

0.04 (0.18)a

Extrapolation factor

ISEF

1d

Fraction unbound

fumic

1d

Adult enzyme expression (mg enzyme/g tissue)

UGT1A3

0.016d

UGT1A4

0.017d

DME j

f m,UGT (% contribution of DME j )

K m (µM)

V max (pmol/min/pmol DME j ) f

\({{\rm{C}}{\rm{L}}{\rm{u}}}_{{{\rm{i}}{\rm{n}}{\rm{t}}{\mathtt{,}}{\mathtt{\text{DME}}}}_{{\mathtt{j}}}}\) (L/h) g

UGT1A3

0.086 (10)h

70h

0.96

0.39

UGT1A4

0.774 (90)h

550h

65.54

3.52

  1. Abbreviations: LogP, partition coefficient; pKa, dissociation constant; B:P, blood to plasma concentration ratio; fup, unbound fraction in the plasma; ACAT, advanced compartmental absorption and transit; Peff, effective permeability; Vss, volume of distribution at steady state; CLIV, intravenous plasma clearance; fCL,renal, fraction of drug cleared unchanged renally; CLR, renal plasma clearance; fCL,hepatic, fraction of drug cleared through hepatic metabolism; CLH, hepatic plasma clearance; CLuint,H, unbound hepatic intrinsic clearance; fm,DME, fraction of drug metabolized by a specific drug metabolizing enzyme isoform (DMEj); ISEF, inter-system extrapolation factor; fumic, unbound fraction in the microsomes; Km, concentration of substrate at which half-maximal enzymatic activity (Vmax) is reached, and CLuint, unbound intrinsic clearance for a particular metabolic pathway. For method/references, details are as follows: a54, b49, c65, dDefault value in GastroPlus, eOptimized according to literature reported65 value in adult by adjusting LogP value (1.629) with Poulin & Theil (homogeneous) method. Similar approach was used for Vss calculation in paediatrics and HI populations, fCalculated using Equation 19, gCalculated using Equation 17, and h46.